Regression of a Large Goiter in a Patient with Resistance to Thyroid Hormone by Every Other Day Treatment with Triiodothyronine

Thyroid

Volumn 14, Issue 1, 2004, Pages 71-74

  Anselmo, João ^a   Refetoff, Samuel ^b  

^a HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SAFETY; FAMILY; FEMALE; GENE MUTATION; GOITER; HORMONE SYNTHESIS; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; SIDE EFFECT; THYROID GLAND; TREATMENT OUTCOME;

CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; GOITER; HUMANS; MUTATION; RECEPTORS, THYROID HORMONE; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES; THYROTROPIN; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 1442334376     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504322783876     Document Type: Article

References (7)

1. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399.
2. Agerbaek H 1973 Congenital goiter presumably resulting from tissue resistance to thyroid hormones. Israel J Med Sci. 8:1859-1860.
3. Elewaut A, Mussche M, Vermeulen A 1976 Familial partial target organ resistance to thyroid hormone. J Clin Endocrinol Metab 43:575-581.
4. Anselmo J, Kay T, Dennis K, Szmulewitz R, Refetoff S, Weiss RE 2001 Resistance to thyroid hormone does not abrogate the transient thyrotoxicosis associated with gestation: report of a case. J Clin Endocrinol Metab 86:4273-4275.
5. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P 1994 Evidence for secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 78:1034-1039.
6. Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S 1997 Resistance to thyroid hormone caused by two mutant thyroid hormone receptors β, R243Q and R243W, with marked impairment of function that cannot be explained by altered in-vitro 3,5,3′-triiodothyronine binding affinity. J Clin Endocrinol Metab 82:1608-1614.
7. Safer JD, Cohen RN, Hollenberg AN, Wondisford FE 1998 Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. J Biol Chem 273:30175-30182.